MACROGOL 4000 CASEN RECORDATI 4G POWDER FOR ORAL SOLUTION IN SACHET Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

macrogol 4000 casen recordati 4g powder for oral solution in sachet

casen recordati sl (0000003744) autovia de logrono km 13,300, utebo-zaragoza, 50180 - macrogol 4000 - powder for oral solution in sachet - 4g - macrogol 4000 (8000014439) 4g

MACROGOL 4000 CASEN RECORDATI 10G POWDER FOR ORAL SOLUTION IN SACHET Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

macrogol 4000 casen recordati 10g powder for oral solution in sachet

casen recordati sl (0000003744) autovia de logrono km 13,300, utebo-zaragoza, 50180 - macrogol 4000 - powder for oral solution in sachet - 10g - macrogol 4000 (8000014439) 10g

Clopidogrel Viatris (previously Clopidogrel Taw Pharma) Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

clopidogrel viatris (previously clopidogrel taw pharma)

viatris limited - κλοπιδογρέλη besilate - peripheral vascular diseases; stroke; myocardial infarction - Αντιθρομβωτικοί παράγοντες - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). Υψόμετρο τμήμα του st οξύ έμφραγμα του μυοκαρδίου, σε συνδυασμό με ΑΣΟ σε ιατρικά ασθενών επιλέξιμων για θρομβολυτική θεραπεία. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. Για περαιτέρω πληροφορίες ανατρέξτε στην παράγραφο 5.

LOGIMAX PR.TAB (5+47,5)MG/TAB Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

logimax pr.tab (5+47,5)mg/tab

recordati industria chimica e farmaceutica spa, italy via m. civitali, 1, 20148 milano, 39 0248787649 - felodipine; metoprolol succinate - pr.tab (ΔΙΣΚΙΟ ΠΑΡΑΤΕΤΑΜΕΝΗΣ ΑΠΟΔΕΣΜΕΥΣΗΣ) - (5+47,5)mg/tab - felodipine 5mg; metoprolol succinate 47,5mg - metoprolol and other antihypertensives

TESGRECO TAB 20MG/TAB Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

tesgreco tab 20mg/tab

iasis pharmaceuticals hellas ΒΙΟΜΗΧΑΝΙΑ ΚΑΙ ΕΜΠΟΡΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ - ΧΗΜΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΙΟΝΤΩΝ Α.Β.Ε.Ε., Δ.Τ. iasis pharma Λ. Φυλής 137,, 134 51 134 51, Καματερό 210.2311031 - telmisartan - tab (ΔΙΣΚΙΟ) - 20mg/tab - telmisartan 20mg - telmisartan